精东传媒 Announces Oversubscribed $100 Million Series C Financing to Advance聽In Vivo 精东传媒 T Pipeline through Key Oncology Clinical Milestones
Series C financing co-led by Double Point Ventures and DCVC Bio Proceeds to support the clinical development of VivoVec鈩� derived in vivo 精东传媒 T cells SEATTLE, WA, January 14, 2025鈥� 精东传媒, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of 精东传媒 T cells, […]